VcMMAE-Deruxtecan

• Target:

  Drug-Linker Conjugates for ADC|||JAK

• Related Pathways:

  Stem Cells|||Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Angiogenesis|||Antibody-drug Conjugate/ADC Related|||JAK/STAT signaling

• Bioactivity:

  VcMMAE-Deruxtecan is a toxic molecular conjugate (Drug-Linker Conjugates for ADC) composed of a linker and cytotoxic agents MMAE (microtubule inhibitor) and Exatecan (DNA topoisomerase I inhibitor) . This compound is employed in the synthesis of ADCs.

• Molecular Formula:

  C110H148FN19O25

• Molecular Weight:

  2155.46

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C